OFIX logo

Orthofix Medical Inc. Stock Price

NasdaqGS:OFIX Community·US$605.1m Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

OFIX Share Price Performance

US$15.47
-0.72 (-4.45%)
31.4% undervalued intrinsic discount
US$22.55
Fair Value
US$15.47
-0.72 (-4.45%)
31.1% undervalued intrinsic discount
US$22.45
Fair Value
Price US$15.47
AnalystConsensusTarget US$22.45
AnalystLowTarget US$17.00

OFIX Community Narratives

AnalystConsensusTarget·
Fair Value US$22.55 31.4% undervalued intrinsic discount

Advanced Orthopedic Solutions Will Serve Expanding Needs In Aging Populations

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystLowTarget·
Fair Value US$17 9.0% undervalued intrinsic discount

Pricing Pressures And Tariffs Will Constrain Margins Yet Allow Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
2 Rewards

Orthofix Medical Inc. Key Details

US$809.0m

Revenue

US$251.8m

Cost of Revenue

US$557.2m

Gross Profit

US$680.9m

Other Expenses

-US$123.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 04, 2025
-3.13
68.88%
-15.29%
34.3%
View Full Analysis

About OFIX

Founded
1980
Employees
1616
CEO
Massimo Calafiore
WebsiteView website
orthofix.com

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Recent OFIX News & Updates

Orthofix Medical: Compelling Valuation Supported By Insider Purchases

Aug 07

Recent updates

No updates